TickerFacts.

Inhibitor Therapeutics, Inc. (INTI): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

172.51M
Year ended 2025-12-31
-22.2%
3-year compound annual growth
376.25M2012-12-31: 13.65M2013-12-31: 17.94M2021-12-31: 376.25M2022-12-31: 366.18M2023-12-31: 171.95M2024-12-31: 172.26M2025-12-31: 172.51M172.51M
2012-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31172.51M+0.1%2026-03-26, From 2025-01-01
2024-12-31172.26M+0.2%2026-03-26, From 2024-01-01
2023-12-31171.95M-53.0%2025-03-28, From 2023-01-01
2022-12-31366.18M-2.7%2024-03-29, From 2022-01-01
2021-12-31376.25Mn/a2023-03-31, From 2021-01-01
No annual figure between 2013-12-31 and 2021-12-31.
2013-12-3117.94M+31.5%2014-04-15, From 2013-01-01
2012-12-3113.65Mn/a2014-04-15, From 2012-01-01